Optimal Timing (Preemptive versus Supportive) of Granulocyte Colony-Stimulating Factor Administration following High-Dose Cyclophosphamide

Publisher： Karger

E-ISSN： 1423-0232|56|1|28-35

ISSN： 0030-2414

Source： Oncology, Vol.56, Iss.1, 1999-01, pp. : 28-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intermediate-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor Is a Valid Alternative to High-Dose Cyclophosphamide for Mobilizing Peripheral Blood CD34+ Cells in Patients with Multiple Myeloma

By  

Acta Haematologica, Vol. 109, Iss. 4, 2003-07 ,pp. : 184-188

Karger

Access to resources Recommend Favorite

A Marked Increase in Myeloblasts in the Peripheral Blood of a Patient with Burkitt Lymphoma following Granulocyte Colony-Stimulating Factor Administration

By  

Acta Haematologica, Vol. 120, Iss. 3, 2008-12 ,pp. : 174-176

Karger

Access to resources Recommend Favorite

Changes in Gene Expression Pattern following Granulocyte Colony-Stimulating Factor Administration to Normal Stem Cell Sibling Donors

By  

Acta Haematologica, Vol. 117, Iss. 2, 2006-11 ,pp. : 68-73

Karger

Access to resources Recommend Favorite

Granulocyte colony-stimulating factor and leukemogenesis

By Lorena Lobo de Figueiredo   Rodrigo Siqueira de Abreu e Lima   Eduardo Magalhães Rego  

Mediators of Inflammation, Vol. 13, Iss. 3, 2004-06 ,pp. : 145-150

Informa Healthcare

Access to resources Recommend Favorite

Prostate Cancer-Producing Granulocyte Colony-Stimulating Factor

By  

Urologia Internationalis, Vol. 82, Iss. 1, 2009-01 ,pp. : 113-115

Karger

Access to resources Recommend Favorite